drugset / Trial / NCT01318369

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain

NCT01318369

Phase 2 Completed 24 enrolled Radboud University Medical Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

The main goal of this trial is to study the efficacy of Namisol® after a single dose of Δ9-THC in the treatment of pain resulting from chronic pancreatitis. Objective measures of pain processing, e.g. encephalography (EEG) and quantitative sensory testing (QST), are included to provide insight in underlying nociceptive processing.

Timeline

Start
2011-10
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diazepam Small molecule 5 mg
Comparator Diazepam Small molecule 10 mg
Subject Dronabinol Other / unclassified 8 mg

Indications